This interaction not only enhances PRKDC promoter binding and transcription but may also establish a self-reinforcing loop through Sp1 phosphorylation by DNA-PKcs, thereby promoting tumor aggressiveness and therapy resistance [12,102,108,109,110,111]. Here, PRKDC is linked to neoplasm.